Today, at a joint meeting of the University of Maryland, Baltimore (UMB) and Johns Hopkins University, Pataigin was awarded a $25,000 Maryland Department of Commerce Life award for Pataigin’s application of lipid fingerprint technology licensed from UMB. Pataigin has developed a test, called BACLIB, that inexpensively identifies bacteria and fungi causing infections in less than an hour. Pataigin plans on using its award funding to validate tests for high-priority antibiotic-resistant microbes such as ESKAPE pathogens, which include Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter, Pseudomonas aeruginosa and Enterobacter.
“We are very pleased to see the incredible growth of faculty entrepreneurship since the formation of the UMB New Ventures group two and a half years ago, and equally proud of our faculty’s enthusiasm for, and dedication to, translational research,” said Phil Robilotto, chief commercialization officer of UM Ventures.
In addition, Pataigin founder Prof. Robert Ernst was honored for his work developing a new method to treat bacterial sepsis, a blood-borne bacterial infection that affects approximately one million people in the United States.